2005 Labelling Vaccines 
Pharma in Brief
AUGUST 3, 2023
Background The prior version of the Distinction Guidance was last updated in August 2005 (the Old Guidance ) and did not adequately address the evolution of advertising activities since that time, including online advertising, search engine marketing, and social media activities. Patient information.
PharmaShots
APRIL 13, 2023
The company also granted exclusive marketing rights to Meda for Cibacen and Cibadrex in major EU markets for $0.13B In the year 2005, Bayer’s sales depicted an increase of 18%, attributable mainly due to its consumer health business acquired from Roche Abbott achieved a total revenue of $1.4B compared to 2015. to the total revenue.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaShots
MARCH 9, 2023
She developed various mobile technologies and pioneered early electronic labels including NFC tags, which helped Thin Film Electronics win the Wall Street Innovation Award and the Global Technology Award. Designation: Global Head Previous company: Merck Global Vaccines (2 yrs. LinkedIn Total experience: 16 yrs.
European Pharmaceutical Review
SEPTEMBER 22, 2023
Active anti-Abeta immunotherapies In the 2000s, the concept of active immunotherapy targeting Abeta in Alzheimer’s patients was assessed with the ELAN vaccine (AN1792), consisting of full-length aggregated Abeta 1-42 peptide mixed with the QS21 adjuvant. 8 However, as this trial was not placebo-controlled, conclusions are difficult to draw.
European Pharmaceutical Review
AUGUST 10, 2022
countries with manufacturing capacity for diagnostics, vaccines and therapeutics. Monkeypox is a disease caused by a zoonotic orthopoxvirus (the monkeypox virus) with similar but less severe symptoms to smallpox – a related disease eradicated through vaccination campaigns by May 1980 – including a rash and fever. But what is monkeypox?
Expert insights. Personalized for you.
52 
Let's personalize your content